Analyzing Quidel (QDEL) and Restoration Robotics (HAIR)
Quidel (NASDAQ: QDEL) and Restoration Robotics (NASDAQ:HAIR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings.
Earnings & Valuation
This table compares Quidel and Restoration Robotics’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Quidel||$277.74 million||5.99||-$8.16 million||($0.24)||-198.75|
|Restoration Robotics||$21.30 million||8.03||-$17.84 million||$0.02||295.50|
This table compares Quidel and Restoration Robotics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider & Institutional Ownership
93.4% of Quidel shares are held by institutional investors. Comparatively, 25.9% of Restoration Robotics shares are held by institutional investors. 22.0% of Quidel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This is a summary of current recommendations for Quidel and Restoration Robotics, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Quidel presently has a consensus price target of $54.20, indicating a potential upside of 13.63%. Restoration Robotics has a consensus price target of $8.75, indicating a potential upside of 48.05%. Given Restoration Robotics’ higher possible upside, analysts clearly believe Restoration Robotics is more favorable than Quidel.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.
About Restoration Robotics
Restoration Robotics, Inc. is a medical device company. The Company designs and develops the ARTAS Robotic Hair Transplant System, a physician-assisted system to harvest follicular units directly from the scalp and create recipient implant sites using algorithms. It offers machine vision, image guidance, visual servoing and robotics, as well as develops interfaces to manage these technologies. With the ARTAS Hair Studio application, physicians design personalized recipient site patterns on a three-dimensional (3D) patient model and transfer the aesthetic plan to the ARTAS Robotic System. The ARTAS Hair Studio application is a 3D patient consultation tool. Using actual patient photographs, the physician can create a simulated hair transplant model, which may be shared with the patient. The ARTAS Hair Studio application allows the physician to develop aesthetic plans with direct input from the patient. It also offers a solution, The ARTAS Robotic procedure.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.